Stock kasuwa, musayar ciniki a yau
Rahoton samfurori na kamfanonin 71229 a ainihin lokacin.
Stock kasuwa, musayar ciniki a yau

Rahoton samfurori

Stock ya faɗi a kan layi

Stock ya faɗi tarihi

Kasashen kasuwancin jari

Stock dividends

Riba daga kamfanin kamfanoni

Rahotan kuɗi

Ƙididdiga na kamfanoni. A ina zan zuba kudi?

Neurocrine Biosciences, Inc. kasuwar kasuwa

Matsayin kasuwancin jari na Neurocrine Biosciences, Inc. a yau da kuma tarihin ƙaddamar da Neurocrine Biosciences, Inc. daga farkon kasuwanci a NBIX hannun jari akan musayar jari.
Ƙara zuwa widget din
Ƙara zuwa widget din

Neurocrine Biosciences, Inc. girma

Yau kasuwa kasuwa na Neurocrine Biosciences, Inc. shine 10 022 526 976 US dollar.
+404 551 680 $ (+4.21%)
canji na strongn kudi tun jiya

Mene ne tsarin mulkin Neurocrine Biosciences, Inc. a yau. Neurocrine Biosciences, Inc. capitalization a yau ana ɗaukar su a matsayin jimlar duk abin da aka ambata Neurocrine Biosciences, Inc.. Bayanin Neurocrine Biosciences, Inc. an karɓi iko daga manyan hanyoyin. Neurocrine Biosciences, Inc. karfafan haɓaka ya karu da $ 404 551 680.

Neurocrine Biosciences, Inc. girma na kasuwanci

Yau yaudarar kasuwancin jari Neurocrine Biosciences, Inc. ya kai 229 855 US dollar.
-1 680 378 $ (-87.97%)
canjin karuwar kasuwancin tun jiya

Neurocrine Biosciences, Inc. Darajar ciniki a yau shine 229 855 dalar Amurka. A yau, Neurocrine Biosciences, Inc. ciniki ya gudana a kasuwannin hannayen jari daban-daban. Neurocrine Biosciences, Inc. an gabatar da ginshiƙi mai ciniki a shafin yau da kullun. Neurocrine Biosciences, Inc. kasuwar tafiya ta yi kasa a jiya.

Nuna:
To

Neurocrine Biosciences, Inc. kasuwar kasuwa

Neurocrine Biosciences, Inc. aikin kwalliya akan zane a shekaru. A cikin sati, Neurocrine Biosciences, Inc. karfin kai ya canza daga -1.15%. 0% a kowace shekara - wani canji a cikin kasuwar kasuwancin Neurocrine Biosciences, Inc.. A yau, ana ƙididdigar harajin Neurocrine Biosciences, Inc. a 10 022 526 976 dalar Amurka.

Week Watan 3 months Shekara 3 shekaru

Neurocrine Biosciences, Inc. tarihin lalata

Kwanan Girma
Babban jari (kasuwannin kasuwa) shine kasuwa na kasuwa na kamfanonin da ke sayarwa akan musayar jari. Mahimmancin kasuwancin yana daidai da farashin hannun jari da yawa ta hanyar yawan kuɗi.
04/05/2023 10 022 526 976 $
03/05/2023 9 617 975 296 $
02/05/2023 10 053 913 600 $
01/05/2023 10 144 612 352 $
28/04/2023 9 756 948 480 $
27/04/2023 9 898 848 256 $
26/04/2023 10 139 215 872 $

Neurocrine Biosciences, Inc. tashar girma

Week Watan 3 months Shekara 3 shekaru

Neurocrine Biosciences, Inc. bayanan tarihi na tarihi

Kwanan Volume (24h)
Ƙaramar kasuwancin Neurocrine Biosciences, Inc. hannun jari shine yawan yawan ma'amaloli tare da hannun jari na NBIX da aka saya a lokacin da aka zaba.
04/05/2023 229 855 $
03/05/2023 1 910 233 $
02/05/2023 189 027 $
01/05/2023 731 825 $
28/04/2023 497 029 $
27/04/2023 64 615 $
26/04/2023 287 040 $

04/05/2023 Neurocrine Biosciences, Inc. karfaffen kaya ya kai 10 022 526 976 Dalar Amurka. Neurocrine Biosciences, Inc. karfaffen kaya ya kasance zuwa 9 617 975 296 Dalar Amurka a 03/05/2023. A 02/05/2023, Neurocrine Biosciences, Inc. taken kasuwa shine $ 10 053 913 600. A 01/05/2023, Neurocrine Biosciences, Inc. taken kasuwa shine $ 10 144 612 352.

Neurocrine Biosciences, Inc. capitalization daidai yake da 9 756 948 480 Dalar Amurka a 28/04/2023. Neurocrine Biosciences, Inc. capitalization a 27/04/2023 sun kasance masu yawa 9 898 848 256 dalar Amurka. Babban tsarin kasuwancin Neurocrine Biosciences, Inc. a 26/04/2023 wanda aka kimanta zuwa 10 139 215 872 dalar Amurka.

A capitalization na Neurocrine Biosciences, Inc. a yau shi ne 10 022 526 976 $. Girman kasuwa na Neurocrine Biosciences, Inc. ya canza zuwa +4.21% idan aka kwatanta da jiya. Hanyoyin ciniki na NBIX hannun jari na Neurocrine Biosciences, Inc. a rana ta ƙarshe ta kasuwanci ya kasance 229 855 $. Ƙarin ciniki na Neurocrine Biosciences, Inc. ya canza zuwa -87.967% idan aka kwatanta da ranar ciniki.

Kudin hannun jari Neurocrine Biosciences, Inc.

Finance Neurocrine Biosciences, Inc.